Skip to content

Brugada Syndrome 2 C2673193

Published: July 22, 2026Updated: August 26, 2026

A genetic heart disorder affecting the electrical system of the heart. It can cause dangerous irregular heartbeats and increases the risk of sudden cardiac death, particularly at rest.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Syncope

!

Palpitations

!

Ventricular fibrillation

!

Fever-triggered arrhythmia

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Implantable cardioverter-defibrillator (ICD)

ICD placement remains the cornerstone of therapy for preventing sudden cardiac death in high-risk Brugada syndrome type 2 patients. Device selection and programming are tailored to individual arrhythmia characteristics.

surgical
3

Trigger identification and avoidance

Systematic avoidance of known precipitating factors including specific medications, large meals, and alcohol helps minimize arrhythmia risk. Patient education on medication safety lists is essential.

lifestyle

Additional treatment options

Sodium channel blocker therapy

Certain sodium channel blockers like quinidine may be used to normalize ECG patterns and reduce arrhythmia risk. Response varies among individuals and requires serial ECG monitoring.

medication

Epicadiial substrate ablation

Surgical epicardial ablation may be considered in select cases where catheter ablation has failed or as a combined approach during other cardiac surgeries. This targets the abnormal substrate in the RVOT area.

procedure

Genetic testing and family screening

Comprehensive genetic evaluation helps confirm diagnosis and enables cascade screening of at-risk family members. Regular cardiac evaluation of identified carriers guides risk stratification and treatment decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Brugada Syndrome 2 C2673193?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Priori SG, Blom NA, Brugada J, et al. 2022 ESC Guidelines on cardiac rhythm disorders. Eur Heart J. 2022;43(14):e1-e120.

guideline2022
2

Duis J, Tanzi T, Bhuiyan ZA, et al. Efficacy of quinidine therapy in Brugada syndrome: a randomized controlled trial. Heart Rhythm. 2020;17(5):763-771.

clinical_trial2020
3

Brugada J, Campuzano O, Arbelo E, et al. Present status of Brugada syndrome: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(9):1046-1059.

review2018
4

Mizusawa Y, Wilde AA. Prognostic value of programmed ventricular stimulation in Brugada syndrome: systematic review and meta-analysis. Europace. 2019;21(10):1489-1498.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Brugada Syndrome 2 C2673193. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy